Shaping Discovery, Improving Life

Awards & Recognition

Company of the Year

2009 Frost & Sullivan Drug Discovery Technologies Company of the Year

Frost and Sullivan AwardFrost & Sullivan recognizes Life Technologies with the 2009 North American Frost & Sullivan Company of the Year Award. The company’s size, product portfolio breadth, market segment leadership, and strong future potential set it apart from any competitor in the life science research tools industry. Moreover, Life Technologies shows great commitment to providing innovative and enabling tools across the life science research continuum.

More Awards & Recognition

* 2009 - Newsweek Magazine - Life Technologies listed among America's 500 largest green corporations
* 2009 - Frost & Sullivan Drug Discovery Technologies Company of the Year
* 2009 - Frost & Sullivan Drug Discovery Technologies CEO of the Year
* 2009 - BBBOnLine Accreditation
* 2008 - TIME Magazine - SPOT-Light HER2 CISH Kit named in Top 10 Medical Breakthroughs
* 2008 - The Scientist - SOLiD Named Top Innovation of 2008
* 2008 - Connect - Most Innovative Product Finalist, StemPro BG01v platform cell engineering kit
* 2008 - San Diego Urban League, Urban Legacy Award for Environmentalism and Sustainability
* 2008 - APEX Award of Excellence, Print Publications, 32+ pages - Invitrogen's Quest (Vol. 4, Issue 2)
* 2008 - APEX Award of Excellence, Design & Layout - BioProbes 55 Magazine
* 2008 - Life Science Industry Awards - Cell Biology Kits and Reagents
* 2008 - Life Science Industry Awards - Cell Culture Media and Reagents
* 2008 - Life Science Industry Awards - Most Responsive Customer Service
* 2008 - Life Science Industry Awards - Most Knowledgeable Technical Support
* 2008 - Life Science Industry Awards - Most Useful Website

News

  • SOLiD 4 Announced

    Company announces SOLiD(TM) 4 System, delivering industry's most cost effective, highest quality genome for $6,000, reduced to $3,000 by end of 2010 with SOLiD(TM) 4hq upgrade.

    Read All Close

  • LT & Ignite Institute

    Life Technologies and the Ignite Institute for Individualized Health for a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia. Ignite will acquire 100 of the Applied Biosystems SOLiD(TM) 4 Systems, the most advanced next generation DNA sequencing platform on the market, establishing the largest concentration of genetic analytical power in North America.

    Read All Close

  • Q4 & FY09 Results

    Life Technologies today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

    Read All Close

Life (Common Stock)

Sustainability Indexes

The former Invitrogen Corporation was selected as a new member of the Dow Jones Sustainability World Index (DJSI World) and named leader of the biotechnology sector for 2008. The company ranked in the top 10% of the world's 2,500 largest companies in terms of sustainability for performance in corporate governance, labor practices, talent development, community involvement, workplace safety, climate change, and environmental management. Life Technologies was named to the FTSE4Good Index Series, an equity index series that facilitates investment in companies that meet globally recognized citizenship standards, in March 2009.

© 2010 Life Technologies Corporation. All Rights Reserved